亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection

呼吸系统 病毒学 医学 病毒 儿科 重症监护医学 内科学
作者
Shunying Zhao,Yunxiao Shang,Yong Yin,Yingxue Zou,Yongsheng Xu,Li-Li Zhong,Hailin Zhang,Hua Zhang,Deyu Zhao,Tong Shen,Dongming Huang,Qiang Chen,Qiaozhi Yang,Yungang Yang,Xiaoyan Dong,Ling Li,Zhi‐Min Chen,Enmei Liu,Li Qin Deng,Wenhui Jiang
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:391 (12): 1096-1107 被引量:72
标识
DOI:10.1056/nejmoa2313551
摘要

Background Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the treatment of infants hospitalized with RSV infection. Methods In a phase 3, multicenter, double-blind, randomized, placebo-controlled trial conducted in China, we enrolled participants 1 to 24 months of age who were hospitalized with RSV infection. Participants were randomly assigned, in a 2:1 ratio, to receive ziresovir (at a dose of 10 to 40 mg, according to body weight) or placebo, administered twice daily, for 5 days. The primary end point was the change from baseline to day 3 (defined as 48 hours after the first administration) in the Wang bronchiolitis clinical score (total scores range from 0 to 12, with higher scores indicating greater severity of signs and symptoms). The intention-to-treat population included all the participants with RSV-confirmed infection who received at least one dose of ziresovir or placebo; the safety population included all the participants who received at least one dose of ziresovir or placebo. Research Summary Ziresovir in Hospitalized Infants with RSV Infection Results The intention-to-treat population included 244 participants, and the safety population included 302. The reduction from baseline in the Wang bronchiolitis clinical score at day 3 was significantly greater with ziresovir than with placebo (−3.4 points [95% confidence interval {CI}, −3.7 to −3.1] vs. −2.7 points [95% CI, −3.1 to −2.2]; difference, −0.8 points [95% CI, −1.3 to −0.3]; P=0.002). The reduction in the RSV viral load at day 5 was greater in the ziresovir group than in the placebo group (−2.5 vs. −1.9 log 10 copies per milliliter; difference, −0.6 log 10 copies per milliliter [95% CI, −1.1 to −0.2]). Improvements were observed in prespecified subgroups, including in participants with a baseline bronchiolitis score of at least 8 and in those 6 months of age or younger. The incidence of adverse events related to the drug or placebo was 16% with ziresovir and 13% with placebo. The most common adverse events that were assessed by the investigator as being related to the drug or placebo were diarrhea (in 4% and 2% of the participants, respectively), an elevated liver-enzyme level (in 3% and 3%, respectively), and rash (in 2% and 1%). Resistance-associated mutations were identified in 15 participants (9%) in the ziresovir group. Conclusions Ziresovir treatment reduced signs and symptoms of bronchiolitis in infants and young children hospitalized with RSV infection. No safety concerns were identified. (Funded by Shanghai Ark Biopharmaceutical; AIRFLO ClinicalTrials.gov number, NCT04231968 .)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
笑点低的丹蝶完成签到,获得积分10
10秒前
专一的思菱完成签到,获得积分10
18秒前
Maestro_S的应助被科研通管家采纳,获得10
20秒前
20秒前
28秒前
41秒前
zhengjia发布了新的文献求助30
45秒前
动听的山槐完成签到,获得积分10
45秒前
孝顺的怜寒完成签到,获得积分10
45秒前
51秒前
1分钟前
深情安青的应助被zhengjia采纳,获得10
1分钟前
能干的孱完成签到,获得积分10
1分钟前
JiaxinChen完成签到 ,获得积分10
1分钟前
满意的楷瑞完成签到,获得积分10
1分钟前
陆上飞完成签到,获得积分10
1分钟前
1分钟前
1分钟前
游标卡尺发布了新的文献求助10
1分钟前
含蓄的觅波完成签到,获得积分10
2分钟前
彭于晏的应助被游标卡尺采纳,获得10
2分钟前
Owen的应助被笑点低听枫采纳,获得10
2分钟前
2分钟前
个性鹭洋完成签到,获得积分10
2分钟前
昌莆完成签到 ,获得积分10
2分钟前
2分钟前
安静的卿完成签到,获得积分10
2分钟前
滕皓轩完成签到 ,获得积分20
3分钟前
3分钟前
3分钟前
游标卡尺发布了新的文献求助10
3分钟前
顾矜的应助被游标卡尺采纳,获得10
3分钟前
呆萌保温杯完成签到,获得积分10
3分钟前
3分钟前
踏实的元蝶完成签到,获得积分10
3分钟前
Mario发布了新的文献求助10
3分钟前
3分钟前
英俊的铭的应助被ZZWZHENG采纳,获得50
3分钟前
Sunny完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570159
关于积分的说明 21808414
捐赠科研通 7775796
什么是DOI,文献DOI怎么找? 3433231
关于科研通互助平台的介绍 2557352
邀请新用户注册赠送积分活动 2478935